Diethyl ether fraction of Labrasol having a stronger absorption enhancing effect on gentamicin than Labrasol itself

被引:16
作者
Hu, ZP [1 ]
Prasad, R
Tawa, R
Konishi, T
Ishida, M
Shibata, N
Takada, K
机构
[1] Kyoto Pharmaceut Univ, Dept Phrmacokinet, Yamashima Ku, Kyoto 6078414, Japan
[2] Kyoto Pharmaceut Univ, Dept Analyt & Bioinorgan Chem, Yamashima Ku, Kyoto 6078414, Japan
基金
日本学术振兴会;
关键词
gentamicin sulfate (GM); absorption enhancement; Labrasol; diethyl ether fraction of Labrasol; extraction; rat colon;
D O I
10.1016/S0378-5173(01)00967-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In our previous study, we had reported that Labrasol has a good gastrointestinal (GI) absorption enhancing effect on poorly absorbable drugs. In order to improve further absorption enhancing effect of Labrasol on gentamicin (GM), which is a representative water-soluble, poorly absorbable drug, Labrasol was fractionated with hexane, diethyl ether, ethyl acetate and water. The absorption enhancing effect of each fraction of Labrasol and Labrasol alone were evaluated in vivo using rats. Each test formulation of GM was administered into the rat colon at a dose of 5.0 mg/kg and plasma GM concentrations were measured by a HPLC method. Among the four fractions of Labrasol and Labrasol, diethyl ether fraction showed the strongest absorption enhancing effect on GM. When the doses of diethyl ether fraction were 1.0, 0.5 and 0.1 ml/kg, the C-max values were 8.95 +/- 1.46, 8.02 +/- 2.14 and 7.41 +/- 1.25 mug/ml, respectively. Moreover, AUC(0-6) values were also maintained at high level, i.e. 27.28 +/- 5.90, 20.32 +/- 3.79 and 19.61 +/- 2.09 mug h/ml. Based on the AUC(0-6) Values obtained with each fraction, the rank order of absorption enhancing effect on GM was diethyl ether > ethyl acetate is approximately equal to hexane > aqueous fraction. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:223 / 235
页数:13
相关论文
共 27 条
  • [1] ASSAY OF GENTAMICIN IN SERUM BY HIGH-PRESSURE LIQUID-CHROMATOGRAPHY
    ANHALT, JP
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1977, 11 (04) : 651 - 655
  • [2] Intestinal transport of gentamicin with a novel, glycosteroid drug transport agent
    Axelrod, HR
    Kim, JS
    Longley, CB
    Lipka, E
    Amidon, GL
    Kakarla, R
    Hui, YW
    Weber, SJ
    Choe, S
    Sofia, MJ
    [J]. PHARMACEUTICAL RESEARCH, 1998, 15 (12) : 1876 - 1881
  • [3] PREDICTABILITY OF BLOOD-LEVELS OF GENTAMICIN IN MAN
    BARZA, M
    BROWN, RB
    SHEN, D
    GIBALDI, M
    WEINSTEIN, L
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1975, 132 (02) : 165 - 174
  • [4] BERKOVITCH M, 1993, ISRAEL J MED SCI, V29, P216
  • [5] Chiba Takashi, 2001, Journal of Nippon Medical School, V68, P340, DOI 10.1272/jnms.68.340
  • [6] LIPID MICROEMULSIONS FOR IMPROVING DRUG DISSOLUTION AND ORAL ABSORPTION - PHYSICAL AND BIOPHARMACEUTICAL ASPECTS
    CONSTANTINIDES, PP
    [J]. PHARMACEUTICAL RESEARCH, 1995, 12 (11) : 1561 - 1572
  • [7] GENTAMICIN
    COX, CE
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 1970, 54 (05) : 1305 - &
  • [8] DRABU YJ, 1990, DRUG EXP CLIN RES, V16, P557
  • [9] EAIMTRAKARN S, IN PRESS J DRUG TARG
  • [10] Gastrointestinal mucoadhesive patch system (GI-MAPS) for oral administration of G-CSF, a model protein
    Eiamtrakarn, S
    Itoh, Y
    Kishimoto, J
    Yoshikawa, Y
    Shibata, N
    Murakami, M
    Takada, K
    [J]. BIOMATERIALS, 2002, 23 (01) : 145 - 152